By NewsDesk @bactiman63
Taiwan’s Department of Disease Control (CDC) announced the first confirmed, imported case of chikungunya of 2021.
The patient is a Indonesian male in his 20s. He came to work in Taiwan on March 16.
When he arrived in Taiwan, he was found to be suffering from a fever. Quarantine officers then tested him for dengue fever, but the results came back negative.
After receiving the negative results, he was tested for COVID-19 and transported to a hospital to undergo medical treatment. Blood tests taken at the airport revealed he was positive for chikungunya fever.
Since chikungunya was first designated a notifiable communicable disease in 2007, Taiwan has recorded a total of 232 confirmed cases, including 21 locally acquired cases.
Chikungunya is a viral disease transmitted to humans by infected mosquitoes. It causes fever and severe joint pain, which is often debilitating. Other symptoms include muscle pain, headache, nausea, fatigue, and rash.
The disease shares some clinical signs with dengue and Zika, and can be misdiagnosed in areas where they are common. As there is no cure, treatment is focused on relieving the symptoms.
- AstraZeneca vaccine prevents COVID-19 according to results from a large clinical trial
- Canada orders more IMVAMUNE smallpox vaccine
- Mexico: Chickenpox cases up in Quintana Roo state
- China reports human H5N6 avian influenza death in Guangxi
- 80% of those testing positive for the COVID-19 virus would be protected against becoming infected again: Danish study
- Nigeria reports 30 additional confirmed Lassa fever cases
- Finland reports two CVST cases, suspends AstraZeneca vaccine use
- Leishmania: Dogs infected with the parasite smell more attractive to female sandflies